There is an error in the eleventh paragraph of the Results section. The correct paragraph is: In *C*. *elegans* DAF2/DAF16 controls the expression of various effector genes including those relevant for detoxification and antimicrobial activity such as the superoxidase dismutase gene *sod-3* and antimicrobial genes *spp-1* and *lys-7* \[23,38\]. Thus given that the precise molecular target/s for violacein in *C*. *elegans* are unknown we sought to determine which, if any, of these relevant downstream genes are required for the increased resistance to violacein observed in daf-2 null and DAF-16 over-expressing strains. Specifically we chose to test violacein sensitivity in *C*. *elegans* mutants defective in *sod-3*, *spp-1* and *lys-7* ([Table 2](#pone.0210026.t001){ref-type="table"}) because of the previous reported involvement of these genes in immunity to bacterial accumulation \[39,40,41\]. We found that *daf-2;sod-3* double mutant displayed significantly reduced survival compared to the single mutant *daf-2* (p\<0.0001, [Fig 6A](#pone.0210026.g001){ref-type="fig"}) when exposed to the 20G8 clone in a nematode killing assay. Interestingly a single mutation in gene spp-1 significantly reduced the nematode's life span when compared to wild type animals (p\<0.0001), while the viability of the nematode was not affected by mutations in the *lys-7* and *sod-3* genes (p\>0.05, [Fig 6B](#pone.0210026.g001){ref-type="fig"}). These data indicate that resistance to violacein in *daf-2* mutants is at least in part driven by SPP-1 and SOD-3, with the antimicrobial LYS-7 having little or no involvement.

[Fig 6](#pone.0210026.g001){ref-type="fig"} is incorrect. Please see the corrected [Fig 6](#pone.0210026.g001){ref-type="fig"} here.

![Nematode killing assay (wild type animals and *daf-2*, *daf-2;sod-3*, *spp-1*, *lys-7*, *sod-3* mutant nematodes vs the 20G8 clone).\
(A) The survival of the nematode was tested using *C*. *elegans* double mutant *daf-2;sod-3*, and (B) the single mutant animals *sod-3*, *spp-1*, and *lys-7*. Each data point represents means ± the standard error of three replicate plates. p values were calculated on the pooled data of all of the plates done in each experiment by using the log-rank (Mantel--Cox) method and the values are provided in the text.](pone.0210026.g001){#pone.0210026.g001}

[Table 2](#pone.0210026.t001){ref-type="table"} is incorrect. Please see the corrected [Table 2](#pone.0210026.t001){ref-type="table"} here.
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###### *C*. *elegans* strains used in this study.

![](pone.0210026.t001){#pone.0210026.t001g}

  Strain name   Genotype/allele designation                  Relevant characteristics                                                                              Source or reference
  ------------- -------------------------------------------- ----------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------
  N2 Bristol    *C*. *elegans* wild isolate                  Wild type isolate                                                                                     CGC[^a^](#t001fn001){ref-type="table-fn"}
  CU1546        *smIs34*                                     ced-1p::ced-1::GFP + *rol-6(su1006)*                                                                  CGC[^a^](#t001fn001){ref-type="table-fn"}
  CB1370        *daf-2*(*e1370*) III                         Mutated in the insulin-like receptor DAF-2. Temperature sensitive dauer constitutive                  CGC[^a^](#t001fn001){ref-type="table-fn"}
  IU10          *daf-16*(*mgDf4*7) I; *rrf-3*(*pk1426*) II   Mutated in the FOXO-family transcription factor DAF-16                                                CGC[^a^](#t001fn001){ref-type="table-fn"}
  TJ356         *zIs356* IV                                  Integrated DAF-16::GFP roller strain. Daf-c, Rol, fluorescent DAF-16::GFP. Overexpression of DAF-16   CGC[^a^](#t001fn001){ref-type="table-fn"}
  JT9609        *pdk-1 (Sa680)* x                            Mutation in the gene encoding for 3-phosphoinositide-dependent protein kinase                         CGC[^a^](#t001fn001){ref-type="table-fn"}
  RB1178        *wwp-1(ok1102) I*.                           Mutation in the gene encoding for the WW domain protein 1                                             CGC[^a^](#t001fn001){ref-type="table-fn"}[^b^](#t001fn002){ref-type="table-fn"}
  TM127         *daf-2*(*e1370*) III; *sod-3*(*sj134*) X     Double mutant in the insulin-like receptor DAF-2 and in the superoxide dismutase SOD-3                CGC[^a^](#t001fn001){ref-type="table-fn"}
  GA186         *sod-3*(*tm760*) X                           Mutated in the iron/manganese superoxide dismutase SOD-3                                              CGC[^a^](#t001fn001){ref-type="table-fn"}
  RB1286        *lys-7*(*ok1384*) V                          Mutated in the putative antimicrobial lysozyme LYS-7                                                  CGC[^a^](#t001fn001){ref-type="table-fn"}
  RB2045        *spp-1*(*ok2703*) III                        Mutated in the antimicrobial peptide caenopore SPP-1                                                  CGC[^a^](#t001fn001){ref-type="table-fn"}

^a^ *Caenorhabditis* Genetics Center, the University of Minnesota.

^b^ *C*. *elegans* Gene Knockout Project <http://www.celeganskoconsortium.omrf.org>.
